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Abstract
Cystic fibrosis (CF) airway epithelial cells have a reduced mass of ether-linked diacylglycerols which might alter protein
kinase C (PKC)-regulated Cl secretion. PKC regulation of basolateral Na-K-2Cl cotransport (NKCC1) was investigated in
CF nasal polyp epithelial cells and a CF/T43 cell line to ascertain whether PKC signaling was altered in CF. NKCC1 was
detected as bumetanide-sensitive 86Rb influx. Methoxamine, a K1-adrenergic agonist, increased PKC activity in cytosol and a
particulate fraction for a prolonged time period, as predicted from previous studies on the generation of diglycerides induced
with methoxamine. Short-term stimulation of CF/T43 cells for 40 s promoted a shift in PKC-N and -j to a particulate
fraction, increased activity of immune complexes of cytosolic PKC-N and of particulate PKC-j and increased activity of
NKCC1. Pretreatment with antisense oligonucleotide to PKC-N blocked methoxamine-stimulated PKC-N activity, reduced
PKC-N mass by 61.4%, and prevented methoxamine-stimulated activity of NKCC1. Sense and missense oligonucleotide to
PKC-N and antisense oligonucleotide to PKC-j did not alter expression of PKC-N or the effects of methoxamine. These
results demonstrate that PKC-N-dependent activation of NKCC1 is preserved in CF cells and suggest that regulation of
NKCC1 is independent of low ether-linked diglyceride mass. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cloning of mammalian cation-Cl cotransporters
has revealed a high degree of homology based on
deduced amino acid sequences [1,2]. One form of
cation-Cl cotransporter is an epithelial secretory
Na-K-2Cl isoform (NKCC1), which provides for
the basolateral entry for Cl during £uid secretion.
Large airway epithelium of trachea and bronchi ex-
press basolateral Na-K-2Cl cotransport which acts in
concert with apical Cl channels and basolateral
Na,K-ATPase and K channels to produce NaCl se-
cretion [3]. It is presumed that tracheal epithelial Na-
K-2Cl cotransport is the secretory form of cation-Cl
cotransporters and, hence, will be referred to here as
NKCC1 [3]. Cellular events leading to activation of
NKCC1 during secretion are not well understood. In
some cells, NKCC1 is activated by cAMP generating
agents; however, in non-CF tracheal epithelial cells
and cystic ¢brosis (CF) nasal polyp epithelial cells,
NKCC1 is activated by K1-adrenergic agents through
protein kinase C (PKC) [4^6]. Detailed studies of the
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mechanism of signal transduction demonstrated a
coupling between K1-adrenergic receptor and
PtdIns(4,5)P2-dependent PLC resulting in the gener-
ation of inositol tris- and bis-phosphates [7] and di-
acylglycerol [4]. The generation of inositol bis- and
tris-phosphates was transient with peak levels at-
tained before 1 min. The formation of diacylglycerol
was biphasic with peak levels observed at less than
1 min and between 6 and 8 min. However, K1-adren-
ergic stimulation of NKCC1 corresponded only to
the initial diacylglycerol peak and not to the second-
ary peak. More importantly, quantitation of diacyl-
glycerol £ux showed di¡erences between non-CF and
CF cells in the molecular species of diglycerides gen-
erated during K1-adrenergic stimulation [8]. Most
striking was a reduction in the relative mass of
ether-linked diglyceride species, which are thought
to down-regulate PKC activity.
One suggestion from these studies was that CF
cells compensated for defective CFTR, an apical Cl
channel a¡ected by the gene defect in CF, by aug-
menting PKC activity to maintain optimal Cl in£ux
via NKCC1. Indeed, previous studies by this labora-
tory established that CF nasal polyp epithelial cells
were strikingly similar to non-CF tracheal epithelial
cells in the regulation of NKCC1 by K1-adrenergic
agonist, PKC inhibitors and protein phosphatase in-
hibitors [7]. In addition to activation of NKCC1,
PKC has also been implicated in the regulation of
CFTR [9^12]. More importantly, our recent studies
provide evidence for PKC-O regulation of cAMP-de-
pendent activation of CFTR [13].
Molecular cloning has revealed that PKC is a mul-
tigene family consisting of at least 11 di¡erent iso-
types that are classi¢ed as Ca2/diacylglycerol-de-
pendent (K, LI, LII, Q), Ca2-independent but
diacylglycerol-dependent (N, O, R, a) and Ca2/diac-
ylglycerol-independent (j, V/S) [14,15]. Recently, this
laboratory reported that K1-adrenergic stimulation
increased the activity of PKC-N and PKC-j [16]. Be-
cause long-term treatment of cells with phorbol ester
did not diminish PKC mass or activity, we used anti-
sense oligodeoxynucleotides speci¢c for PKC-N or
PKC-j mRNA to gain further information on the
role of each PKC isotype in the activation of
NKCC1. We found that PKC-N was necessary for
activation of NKCC1 in non-CF human tracheal ep-
ithelial cells [6]. A similar approach also allowed us
to link constitutively active PKC-O to modulation of
CFTR [13].
Because of its importance as a potential target for
therapeutic intervention in CF airway epithelial cells,
a PKC signaling pathway was further examined in
CF cells. The goal of the present study was to deter-
mine whether PKC isotype(s) were regulated by K1-
adrenergic stimulation as in non-CF cells despite dif-
ferences in pro¢le of molecular species of diglycer-
ides. Studies were performed on CF nasal polyp epi-
thelial cells and CF/T43 cell line that is used
extensively for studies on mutant CFTR. These stud-
ies are the ¢rst that examine PKC expression, activ-
ity, and function in this cell line.
2. Materials and methods
2.1. Materials
86Rb (speci¢c activity 154 Bq/g Rb, 4200 Ci/g Rb),
[Q-32P]ATP (speci¢c activity 111 TBq/mmol, 3000 Ci/
mol) and a enhanced chemiluminescence kit were
purchased from Amersham Life Science (Arlington
Heights, IL). Polyclonal anti-PKC isotype-speci¢c
antibodies, immunizing peptides, and recombinant
PKC isotypes were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). Methoxamine HCl
was supplied by Burroughs Wellcome (Research Tri-
angle Park, NC) and prazosine HCl by P¢zer Phar-
maceutical (New York, NY). Calphostin was ob-
tained from Calbiochem (La Jolla, CA) and
chelerythrine Cl from Research Biochemicals Inter-
national, (Natick, MA). A protein kinase C assay
system and tissue culture supplies were obtained
from Gibco-BRL, Grand Island, NY. All other
chemicals were reagent grade.
2.2. Cell isolation and culture
Tissue was obtained from non-CF tracheas at the
time of autopsy and from 18 nasal polyp specimens
from CF patients at the time of polypectomy
through the Cystic Fibrosis Center, Case Western
Reserve University. Epithelial cells were isolated
and grown in in vitro cell culture. Dr. J. Yankaskas
(University of North Carolina at Chapel Hill) gener-
ously supplied a human airway epithelial cell line
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CF/T43. The CF/T43 cell line was derived from air-
way epithelial cells of a homozygous vF508 CF pa-
tient using the SV40T gene [17] and was grown on
tissue culture plastic dishes in Keratinocyte Growth
Medium (Clonetics, San Diego, CA) supplemented
with 2.0 Wg/ml bovine pituitary extract, 10 ng/ml epi-
dermal growth factor, 5 Wg/ml insulin, and 0.5 Wg/ml
hydrocortisone. Culture medium was changed at 48-
h intervals until con£uence was reached. Monolayers
expressed bumetanide-sensitive K uptake, indicating
that drugs reached a basolateral surface.
2.3. Oligonucleotide treatment of cells
Oligonucleotides were purchased from Gibco-Life
Technologies (Grand Island, NY). Antisense oligo-
nucleotides were complementary to the translation
initiation region of mRNA speci¢c for mouse
PKC-N (AGGGTGCCATGATGGA, Genbank ac-
cession no. X60304) [18] and human PKC-j (GCT-
CCCTTCCATCTTGGG) [19]. Sense oligonucleo-
tides to PKC-N (TCGATCATGGCACCCT) and
PKC-j (CCCAAGATGGAAGGGAGC) and three
missense oligonucleotides to PKC-N (TCGGAGCT-
AAGGAGGT, CGAGTAGTTAGAGCGG, AGG-
GCGTTACGACGGA) were used as controls. Oligo-
deoxynucleotides were dissolved in sterile deionized
water to a ¢nal concentration of 1 mM and added to
inside wells of cell cultures at a ¢nal concentration of
10 WM in serum-and antibiotic-free culture medium.
Oligonucleotide incubation medium was replaced
every 12 h for 48 h.
2.4. Western blot analysis of protein kinase C isotypes
After cell cultures reached con£uence, culture me-
dium was replaced with HEPES-bu¡ered Hank’s bal-
anced salt, pH 7.5 (HPSS). Cells were treated with
vehicle or drugs of interest at 37‡C. Cells were im-
mediately washed twice with ice-cold PBS, harvested
and assayed for protein. Aliquots were solubilized in
Laemmli bu¡er and subjected to 8% SDS-PAGE.
Protein bands were transferred to polyvinylidene di-
£uoride membranes (Immobilon-P, Millipore, Bed-
ford, MA) and immunoblotted with polyclonal anti-
bodies to speci¢c PKC isotypes. Immunoreactive
protein bands were detected using enhanced chemi-
luminescence and quantitated by laser densitometry.
2.5. Subcellular fractionation of primary cultures
Con£uent cell cultures were washed twice with ice-
cold PBS then harvested in 1.0 ml of ice-cold homog-
enization bu¡er consisting of 50 mM Tris-HCl,
pH 7.5, 2 mM EGTA, 5 mM MgCl2, 10 WM 4-(2-
aminoethyl)benzenesulfonyl£uoride hydrochloride
(AEBSF), and 20 Wg/ml leupeptin. The cells were
homogenized by ultrasonic probe (3U10-s pulses)
and cytosolic and particulate fractions recovered as
described previously [16].
2.6. Immunoprecipitation of PKC isotypes
Cells were grown to con£uence on 60 mm tissue
culture plastic dishes then stimulated with vehicle or
drug of interest. Reactions were stopped by rapid
washing with ice-cold PBS. Cells were immediately
lysed and PKC isotype immunoprecipitated as de-
scribed [16].
2.7. PKC assay
PKC activity in subcellular fractions was assayed
by measuring the incorporation of 32P from [Q-32P]-
ATP into a PKC substrate, AcQKRPSQRSKYL
(Ac-MBP(4^14)), in a protein kinase C assay system
(Gibco-Life Technologies). Kinase activity of im-
mune complexes of PKC isotype was measured by
taking immunoprecipitates to a ¢nal volume of 50 Wl
in assay mixture (50 mM Tris-HCl, pH 7.5, 10 mM
L-mercaptoethanol, 10 mM MgSO4, 40 Wg/ml phos-
phatidylserine, 0.1 WM PMA, 50 WM ATP, 10 Wg/ml
histone-III or 0.1 mM O-peptide, 3 WCi [Q-32P]ATP,
1 mM Na orthovanadate, 1 WM KN-93, and plus
protease inhibitors) and incubating at 30‡C for
15 min. Kinase activity of PKC-O was measured
using a synthetic peptide (O-peptide) based on the
pseudosubstrate region of PKC-O. The reaction was
terminated by addition of 30 Wl glacial acetic acid. A
40-Wl aliquot was spotted on P-81 phosphocellulose
paper, washed, and counting for radioactivity by
Cerenov counting.
2.8. K uptake
NKCC1 activity was measured as bumetanide-sen-
sitive uptake of 86Rb; a congener for K, into CF/T43
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cells grown on six-well tissue culture plastic dishes.
Cells were serum-deprived for 24 h prior to experi-
ments and preincubated for 30 min at 32‡C following
addition of vehicle, 50 WM bumetanide, or drug of
interest in 0.5 ml HEPES-bu¡ered Ringers solution
(HBR), consisting of 10 mM HEPES, 138 mM NaCl,
5 mM KCl, 2.5 mM Na2HPO4, 1.8 mM CaCl2,
1 mM MgSO4, and 10 mM glucose, pH 7.5. After
preincubation, 5 Wl HPR supplemented with 1 WCi
86Rb plus drugs of interest was added to the cell
monolayer to initiate radiotracer uptake. Uptake
was terminated by rapidly removing the radioactive
transport medium and washing the cell monolayer
four times with ice-cold isotonic bu¡er consisting
of 100 mM MgSO4 and 137 mM sucrose [20]. Intra-
cellular radioactivity was extracted by incubating cell
monolayers in 0.1 N NaOH. Aliquots of extract were
assayed for radioactive counts by liquid scintillation
counting and for protein with a Bradford assay kit
using bovine serum albumin as the standard. Intra-
cellular radiotracer content was calculated as nmol
K/mg protein.
2.9. Data analysis
Data are reported as mean þ S.E. To determine the
level of signi¢cance, an unpaired t-test with Welch
correction or analysis of variance followed by Bon-
ferroni multiple comparison post-test was performed
using a GraphPad Instat 3.0 computer program [21].
3. Results
To analyze the expression of PKC isotypes in a
CF/T43 cell line and primary cultures of CF nasal
polyp epithelial cells, identical amounts of protein
from each cell type were applied to SDS-PAGE
gels and analyzed by Western blot analysis. The
amount of protein was within the linear range for
quantitative analysis by chemiluminescence [6]. Im-
munoreactive protein bands to PKC-K, -LII, -N, -O,
and -j that were found in non-CF human tracheal
epithelial cells were also expressed in CF nasal polyp
epithelial cells and in a CF/T43 cell line. PKC-LI, -Q
and -R were not detected. Immunoblot analysis of
subcellular fractions revealed di¡erences in the pat-
tern of distribution of PKC isotypes in each cell type.
In non-CF tracheal epithelial cells, 7% of PKC-K and
12% of PKC-j localized to a particulate fraction and
PKC-LII and -N distributed approximately evenly be-
tween cytosolic and particulate fractions. However,
in CF nasal polyp epithelial cells, 15% of PKC-N was
detected in a particulate fraction and, in a CF/T43
cell line, 22% of PKC-K, 94% of PKC-LII and 18%
of PKC-j were localized to a particulate fraction.
Although markedly di¡erent than non-CF tracheal
epithelial cells, the unique distribution and relative
level of expression of PKC isotypes in CF cells tested
here might re£ect di¡erences in origin of each cell
type and, in addition, transformation of CF/T43 cells
with SV40T antigen.
In non-CF human tracheal epithelial cells, K1-
adrenergic agents stimulate NKCC1 [4] and increase
PKC activity [6] within a short time frame of 6 1
min. When tested in both types of CF cells, methox-
amine, a selective K1-adrenergic agonist, increased
PKC activity, after 40 s, in cytosolic and particulate
fractions of CF nasal polyp epithelial cells and CF/
T43 cells (Table 1). At this time point, the ratio of
PKC activity in methoxamine-treated-cells to PKC
activity in untreated cells was signi¢cantly greater
than 1.0 (P6 0.03 for each cell type). However, as
Fig. 1. Kinase activity of immune complexes of PKC-N and -j
from cells stimulated with methoxamine. Cells were incubated
with vehicle (open bar), 10 WM methoxamine (solid bar), me-
thoxamine plus 10 WM rottlerin (stippled bar) or 50 nM cal-
phostin (crosshatch bar) then lysed with detergent bu¡er. PKC
isotypes were immunoprecipitated and immediately assayed for
kinase activity, as described in Section 2. Total kinase activity
was calculated as fmol/min and is reported as mean þ S.E. for
experiments on ¢ve CF nasal polyp epithelial cell preparations
and on nine separate experiments with CF/T43 cells. Levels of
signi¢cance: *P6 0.05, **P6 0.001 compared to vehicle;
#P6 0.05, ##P6 0.001 compared to methoxamine alone.
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predicted, PKC activity remained elevated in CF
cells after a long-term incubation for 6 min. At this
time, PKC activity in non-CF tracheal epithelial cells
was reduced by 90.0% in a cytosolic fraction
(P6 0.01) and by 82.5% in a particulate fraction
(P6 0.01).
The early response was studied in more detail by
measuring kinase activity of immune complexes of
PKC isotypes, using histone-III as the substrate for
PKC-K, -LII, -N and -j and O-peptide for PKC-O. In
non-CF cells, methoxamine increased PKC-N and
PKC-j activities, but did not a¡ect PKC-K or
PKC-LII activities [16]. Fig. 1 illustrates results
with CF nasal polyp epithelial cells and CF/T43 cells.
In CF nasal polyp epithelial cells, methoxamine in-
creased activity of PKC-j by 1.9 þ 0.3-fold (n = 5,
P6 0.05) but did not signi¢cantly increase activity
of PKC-N (1.2 þ 0.1-fold, n = 5, n.s.). In addition,
the data of Fig. 1 shows that, in CF/T43 cells, me-
thoxamine signi¢cantly increased activity of PKC-N
by 2.9 þ 0.4-fold (n = 8, P6 0.001) and PKC-j activ-
ity by 2.4 þ 0.3-fold (n = 8, P6 0.001). The dual stim-
ulation of two Ca2-independent PKC isotypes mim-
icked ¢ndings in non-CF tracheal epithelial cells [16].
Rottlerin, a selective inhibitor of PKC-N [22], e¡ec-
tively blocked the increase in activity of PKC-N in
CF/T43 cells. Inhibition of activity of PKC-N and
-j by calphostin (Fig. 1) con¢rmed activation of
PKC isotypes in the assay system. These data indi-
cate that the CF/T43 cells, although a transformed
Fig. 3. Stimulation of NKCC1 by K1-adrenergic agonist me-
thoxamine in CF/T43 cells. (A) Time-dependent uptake of
86Rb. Cells were unstimulated (solid square) or stimulated with
10 WM methoxamine in the absence (solid circle) or presence of
50 WM bumetanide (open squares) or 10 WM rottlerin (open
circles). 86Rb uptake was initiated by rapid addition of 1 WCi
86Rb plus methoxamine. At indicated time intervals, uptake
was stopped by washing the cell monolayer four times in ice-
cold isotonic MgSO4-sucrose bu¡er. Intracellular radioactivity
was extracted, counted by Cerenkov counting and calculated as
nmol K/mg protein. (B) Contribution of Na,K-ATPase to
86Rb uptake. Cell monolayers were preincubated with 20 WM
ouabain for 30 min. Uptake was terminated after 2 min incuba-
tion with vehicle (open bars) or with methoxamine (solid bars).
Data represent mean of four to nine independent experiments.
Bars represent 1 S.E. unit. *P6 0.001 compared to vehicle;
#P6 0.005 compared to methoxamine alone.
Fig. 2. K1-Adrenergic agonist promotes translocation of PKC-N
and -j in CF/T43 cells. Cells were incubated with vehicle
(basal) or stimulated for 40 s with 10 WM methoxamine, imme-
diately washed with ice-cold homogenization bu¡er, and lysed.
Cytosolic and particulate fractions were recovered by di¡eren-
tial centrifugation. Aliquots of 20 Wg protein were subjected to
SDS-gel electrophoresis, as described in Section 2. Mass distri-
bution in a particulate fraction is expressed as a percentage of
total band intensity (cytosolic plus particulate). Data are re-
ported as mean þ S.E. for experiments on three separate cell
preparations. Levels of signi¢cance: *P6 0.01 compared to
basal unstimulated cells.
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cell line, retain K1-adrenergic regulation of PKC-N
activity.
In non-CF tracheal epithelial cells, short-term in-
cubation with methoxamine promoted a small, but
signi¢cant, shift in PKC-N and -j to a particulate
fraction, coincident with elevated diacylglycerol lev-
els [4,8]. Redistribution of PKC isotypes was assessed
in CF/T43 cells by densitometric analysis of immu-
noblots for PKC isotypes. Fig. 2 illustrates a sum-
mary of densitometric measurements from four ex-
periments. Methoxamine induced a signi¢cant
increase in the amount of PKC-N and -j localized
to a particulate fraction after a short-term incubation
of 40 s. One paradigm for activation of PKC depicts
increased activity with translocation of PKC mass
from cytosol to a particulate fraction. However, we
found that although activity of particulate PKC-j
increased 1.5 þ 0.1-fold (n = 5, P6 0.03), activity of
particulate PKC-N did not increase (1.4 þ 0.5, n = 6).
Rather, activity of cytosolic PKC-N increased
2.6 þ 0.3-fold (n = 5, P6 0.02). Methoxamine pro-
duced a similar e¡ect in non-CF tracheal epithelial
cells [16]. The results suggest that elevated PKC ac-
tivity reported in Table 1 in a cytosolic fraction cor-
Table 2
E¡ect of oligonucleotides on methoxamine-stimulated on activity of NKCC1 in CF/T43 cells
Oligonucleotide Inhibitor treatment
Bumetanide (experimental/vehicle) Rottlerin (% sensitive)
Untransfected 3.69 þ 0.7 (7) 49.4 þ 4.0 (8)
Antisense PKC-N 1.06 þ 0.2 (3)a 13.6 þ 3.5 (5)
Sense PKC-N 3.04 þ 0.8 (3) 35.6 þ 1.6 (3)
Missense PKC-N 3.11 þ 0.5 (6) 44.8 þ 4.3 (6)
Antisense PKC-j 3.63 þ 0.6 (6) 44.9 þ 9.9 (5)
Values are mean þ S.E. for the number of determinations in parentheses. Cell monolayers were preincubated with 10 WM oligonucleo-
tide for 48 h. Untransfected cells were incubated for the same time period in serum-free culture medium. Cells were preincubated with
50 WM bumetanide or with 10 WM rottlerin for 30 min just prior to measurement of 86Rb uptake. 86Rb uptake was measured at a
¢xed time interval of 2 min. For cells treated with bumetanide, relative activity represents bumetanide-sensitive uptake in methox-
amine-treated cells divided by bumetanide-sensitive uptake in unstimulated cells. Bumetanide-sensitive 86Rb uptake in untransfected
control cells was 11.7 þ 2.9 (n = 5) nmol/mg protein and in methoxamine-treated cells was 39.7 þ 10.7 (n = 8, P6 0.001) nmol/mg pro-
tein. Rottlerin-sensitive uptake is calculated as the di¡erence between methoxamine-stimulated 86Rb uptake in the absence and the
presence of rottlerin divided by methoxamine-stimulated-uptake in the presence of rottlerin times 100.
aP6 0.05, compared to untreated cells.
Table 1
Methoxamine induces a sustained increase in cytosolic and particulate PKC activity in CF cells
Incubation time Relative PKC activity (experimental/vehicle)
Non-CF trachea CF nasal polyp CF/T43 cell line
Cytosolic fraction
40 s 2.22 þ 0.34 (7) 1.56 þ 0.20 (6) 2.23 þ 0.21 (4)
6 min 1.11 þ 0.17 (9)a 1.55 þ 0.11 (6) 1.58 þ 0.14 (4)
Particulate fraction
40 s 3.11 þ 0.37 (5) 2.28 þ 0.25 (5) 2.09 þ 0.22 (4)
6 min 1.37 þ 0.14 (9)a 2.33 þ 0.31 (7) 1.78 þ 0.21 (4)
PKC activity is expressed as a ratio of activity in methoxamine-stimulated cells divided by activity in control or untreated cells. The
range of cytosolic PKC activity in unstimulated cells was 22.4 þ 11.6 (4) pmol/mg protein/min in CF nasal polyp epithelial cells to
45.6 þ 4.3 (4) in CF/T43 cells and of particulate PKC activity was 41.7 þ 11.6 (5) pmol/mg protein/min in CF nasal polyp cells to
42.4 þ 1.5 (4) in CF/T43 cells. These activities were not signi¢cantly di¡erent. Ratios are reported as mean þ S.E. for the number of de-
terminations in parentheses. After incubation with 10 WM methoxamine or vehicle, the reaction was terminated and cytosolic and par-
ticulate fractions were obtained for assay of PKC activity, as described in Section 2.
aP6 0.01, compared to 40 s.
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responded to PKC-N activity and activity reported in
a particulate fraction corresponded to PKC-j activ-
ity.
NKCC1 and its regulation by PKC were next in-
vestigated as bumetanide-sensitive K in£ux, using
86Rb as a congener for K. 86Rb uptake was rapid,
attaining quasiequilibrium by 3 min (Fig. 3A). After
a 30-min preincubation period, rottlerin caused a
small insigni¢cant decrease in radioisotopic uptake
of 11.0 þ 0.01% (n = 3, P = 0.09). Methoxamine in-
creased bumetanide-sensitive K uptake by 3.7-fold
(Fig. 3B), indicating stimulation of NKCC1. Rottler-
in signi¢cantly reduced methoxamine-stimulated
86Rb uptake by 49.4 þ 4.0% (n = 8, P6 0.005) (Fig.
3A). Total 86Rb uptake might include a contribution
from Na,K-ATPase that was next assessed using
ouabain. As shown in Fig. 3B, bumetanide-sensitive
uptake in unstimulated cells accounted for 28.3% of
total 86Rb uptake and ouabain-sensitive uptake ac-
counted for 28.9% of total 86Rb uptake. Take togeth-
er, 57.2% of 86Rb uptake is accounted for as uptake
by two major basolateral electrolyte transporters that
mediate K uptake. Methoxamine increased bumeta-
nide-sensitive uptake by 2.8-fold to 78.4% of total
86Rb uptake. In contrast, the relative contribution
of ouabain-sensitive uptake to total 86Rb uptake
did not signi¢cantly increase. Therefore, methox-
amine selectively activated NKCC1 in CF/T43 cells.
To determine whether PKC-N or -j or both were
required for K1-adrenergic stimulation of NKCCI,
each PKC isotype was selectively downregulated us-
ing an antisense approach. CF/T43 cells were trans-
fected with 10 WM antisense oligonucleotide or, as a
control, sense or missense oligonucleotide to PKC-N
or antisense oligonucleotide to PKC-j for 48 h. As
seen in Table 2, antisense oligonucleotide to PKC-N
decreased bumetanide-sensitive 86Rb uptake by
71.3% and reduced rottlerin-sensitive uptake by
72.5%. Cells treated with sense or missense oligonu-
cleotide to PKC-N or with antisense oligonucleotide
to PKC-j retained a bumetanide-sensitive stimula-
tory response to methoxamine. These results indicate
that antisense oligonucleotide to PKC-N blocked ac-
tivity of NKCC1.
To determine whether treatment with antisense oli-
gonucleotide to PKC-N produced its e¡ect by reduc-
ing PKC activity or PKC mass or both, kinase ac-
tivity was measured in immune complexes of PKC-N
from cells treated with antisense oligonucleotides. As
a control, kinase activity of PKC-j was measured in
the same cells. The data of Table 3 shows that anti-
Fig. 4. Immunoblot analysis of PKC-N. CF/T43 cell cultures
were preincubated for 48 h in serum-free medium (UT) or with
10 WM sense (SS), missense (MS) or antisense (AS) oligonucleo-
tide to PKC-N or antisense oligonucleotide to PKC-j. Cell ly-
sates were prepared and analyzed by immunoblot analysis, as
described in Section 2. The ¢gure represents results from one
out of three separate experiments.
Table 3
E¡ect of oligonucleotides on methoxamine-stimulated activity of PKC isotypes
Isotype Relative activity (experimental/vehicle)
Oligonucleotide pretreatment
None Sense PKC-N Antisense PKC-N Antisense PKC-j
PKC-N 2.71 þ 0.4 (4)a 2.16 þ 0.26 (5)b 1.18 þ 0.16 (5) 2.70 þ 0.61 (6)a
PKC-j 2.66 þ 0.4 (4)b 2.64 þ 0.02 (3)b 2.25 þ 0.22 (6)c 1.07 þ 0.25 (4)
Values are mean þ S.E. for the number of determinations in parentheses. CF/T43 cells were preincubated with 10 WM oligonucleotide
for 48 h before stimulation with 10 WM methoxamine. Relative activity is calculated as (total activity in methoxamine-treated cells)/
(activity in vehicle-treated cells). As a control for oligonucleotide treatment, cell monolayers were incubated for the same time period
in serum-free culture medium.
aP6 0.04
bP6 0.01
cP6 0.002, compared to cells treated with HPSS.
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sense oligonucleotide to PKC-N decreased a methox-
amine-stimulated activity of PKC-N by 64.8%, but
did not a¡ect a robust increase in activity of PKC-
j. Sense oligonucleotide to PKC-N and antisense oli-
gonucleotide to PKC-j did not block stimulation of
PKC-N. However, antisense oligonucleotide to PKC-
j did block an increase in methoxamine-stimulated
activity of PKC-j. Because loss of PKC-N activity
might result from loss of PKC-N mass, we next as-
sessed expression of PKC-N by immunoblot analysis.
As seen in Fig. 4, treatment with antisense oligonu-
cleotide to PKC-N reduced PKC-N mass to 38.6 þ 3.0
(n = 4)% of levels in untreated cells, but did not a¡ect
amounts of PKC-K (83.0 þ 6.4%, n = 6), PKC-LII
(93.7 þ 6.2%, n = 5), PKC-O (95.8 þ 13.7% n = 3), and
PKC-j (102.9 þ 5.0%, n = 6). Antisense oligonucleo-
tide to PKC-j reduced PKC-j to 40.0 þ 5.0% (n = 5)
of levels in untreated cells, but did not alter the
abundance of PKC-N (Fig. 4) or PKC-K, -LII, or -O
(data not shown). Additionally, sense and missense
oligonucleotides did not signi¢cantly alter expression
of PKC-N.
4. Discussion
Antisense technology combined with a traditional
biochemical approach provides compelling evidence,
in this study, for a requirement for PKC-N for rapid
activation of NKCC1 in CF/T43 cells despite a lower
ratio of ether/ester diglycerides compared to non-CF
tracheal epithelial cells. Stimulation of CF cells with
methoxamine, an K1-adrenergic agonist, produced a
rapid and sustained increase in activity of PKC; this
was predicted from previous studies on lipid media-
tors generated during K1-adrenergic stimulation [8].
In CF cells, the relative mass of ether-linked di-
glycerides species was reduced in the presence or
absence of K1-adrenergic stimulation. Thus, even
though K1-adrenergic stimulation increased the
mass of ether- and ester-linked diglycerides, the
ether/ester diglyceride ratio remained lower than
non-CF cells. Because ether-linked diglycerides might
modulate receptor-mediated activity of PKC [23,24],
it was important to discern whether PKC signaling in
CF cells was also altered.
These studies of the biochemical and physiological
consequences of K1-adrenergic stimulation indicate
that CF/T43 cells retain at least the early signaling
events of non-CF tracheal epithelial cells. Treatment
of CF/T43 cells with methoxamine for a short time
period of 40 s increased activity of PKC in cytosol
and a particulate fraction (Table 1) and activity of
PKC-N and -j isotypes (Fig. 1), redistributed PKC-N
and -j to a particulate fraction (Fig. 2) and stimu-
lated activity of NKCC1 (Fig. 3). Consistent with
observations in non-CF tracheal epithelial cells [16],
activity of cytosolic PKC-N and particulate PKC-j
also signi¢cantly increased.
An antisense approach was used to provide evi-
dence for a role for a speci¢c PKC isotype in the
regulation of NKCC1 in CF/T43 cells. Preincubation
with 10 WM antisense oligonucleotides to PKC-N for
48 h decreased methoxamine-mediated activation of
NKCC1 to 28.7% of untransfected cells (Table 2),
decreased K1-adrenergic-mediated increase in activity
of PKC-N to 35.8% of untransfected cells (Table 3)
and reduced the amount of PKC-N to 38.6% of un-
transfected cells. Downregulation of PKC-N mass is
in agreement with a half-life of V24 h for PKC in
vitro [25] and corresponds to a reported 60% loss of
PKC-N in other cell lines treated with antisense oli-
gonucleotide to PKC-N [18]. At the concentrations
used in this study, antisense oligonucleotide to
PKC-N was highly speci¢c for PKC-N. The expression
and activities of PKC-K, -LII, -O and -j were unaf-
fected as was an increase in PKC-j activity by me-
thoxamine. Moreover, responses to methoxamine
were retained in cells treated with sense or missense
oligonucleotide to PKC-N (Tables 2 and 3). Antisense
oligonucleotide to PKC-j blocked methoxamine-
stimulated PKC-j activity (Table 3) and reduced
PKC-j mass by 60%, but did not prevent activation
NKCC1 by methoxamine (Table 2). Thus, CF/T43
cells retain a requirement for PKC-N for activation of
NKCC1 that was observed in non-CF tracheal epi-
thelial cells [6].
Recent studies from this laboratory demonstrated
intracellular signaling of K1-adrenergic agents
through a PtdIns(4,5)P2-dependent PLC, subsequent
biphasic generation of diacylglycerol and activation
of basolateral NKCC1 in CF nasal polyp epithelial
cells [4,7,8]. The studies reported here show that, in
CF/T43 cells, elevated PKC activity after short-term
stimulation with methoxamine coincides with an
early generation of diacylglycerol and activation of
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NKCC1. More importantly, PKC-N di¡erentially
regulates NKCC1, a transporter that is crucial for
a Cl secretory mechanism in airway epithelial cells,
and o¡ers a potential site for manipulation of Cl
secretion in CF cells. Activity of PKC is, moreover,
linked to cystic ¢brosis transmembrane regulator,
CFTR. The PKC activator, phorbol 12-myristate
13-acetate (PMA), a tumor-promoting phorbol ester,
regulates Cl secretion in the large airways [26], in cell
lines stably expressing the cystic ¢brosis transmem-
brane regulator (CFTR) [27], in Xenopus oocytes ex-
pressing CFTR [28], and in epithelia expressing
CFTR [9,12,26,29^32] by a mechanism that involves
phosphorylation of channel protein [33,34]. Regula-
tion of CFTR by PKC is less well understood. One
report implies that PKC-mediated phosphorylation is
essential for acute activation of recombinant CFTR
channels by cAMP-dependent protein kinase [10]. In
a recent study [13], we used oligonucleotides to PKC
isotypes to provide evidence for PKC-O regulation of
cAMP-dependent activation of CFTR. These ¢nd-
ings plus our new study reported here support a
model depicting regulation of Cl secretion by PKC
through targeting of speci¢c PKC isotypes to electro-
lyte transporters that are required for £uid and Cl
secretion. More importantly, the results indicate that
CF airway epithelial cells retain PKC-N regulation of
basolateral NKCC1.
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